MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$8,632,386
EPS
-$0.2
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
6,074,436
7,351,723
6,978,475.5*
3,755,335
General and administrative
2,501,176
2,816,215
4,149,741*
3,124,260
Loss from operations
-8,575,612
-10,167,938
-11,128,216.5*
-6,879,595
Interest income
46
45
55.5*
65
Interest expense
5,581
75,344
-
-
Non-operating expenses
51,239
153,594
368,248.75*
-
Change in fair value of warrant liability
-
-
133,206.25*
-
Total other (expense) income
-56,774
-228,893
-501,399.5*
65
Net loss
-8,632,386
-10,396,831
-11,629,616
-6,879,530
Net loss available to common shareholders
-8,632,386
-10,396,831
-11,629,616
-6,879,530
Basic EPS
-0.2
-0.27
-0.245*
-0.21
Diluted EPS
-0.2
-0.27
-0.379
-0.21
Diluted Average Shares
43,904,159
38,674,663
30,688,730
31,956,686
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss available
to common...
-$8,632,386
(-90.28%↓ Y/Y)
Net loss
-$8,632,386
(-90.28%↓ Y/Y)
Loss from operations
-$8,575,612
(-77.23%↓ Y/Y)
Total other (expense)
income
-$56,774
(-118.79%↓ Y/Y)
Interest income
$46
(-28.13%↓ Y/Y)
Research and development
$6,074,436
(143.03%↑ Y/Y)
General and
administrative
$2,501,176
(6.92%↑ Y/Y)
Non-operating expenses
$51,239
Interest expense
$5,581
Buy us a coffee
OS Therapies Inc (OSTX)
OS Therapies Inc (OSTX)